Arterial Wall in Genetic Disorders: Selected Topics

  • M. Daria Haust


With the exception of one area, the congenital malformations, the available information pertaining to the status of arteries in genetic diseases is meager, fragmented, and at times contradictory. Moreover, some of the normal arterial changes accompanying the development from infancy to adult life1 have been misinterpreted in many reports as representing lesions.


Aortic Wall Tuberous Sclerosis Sickle Cell Trait Primary Hyperoxaluria Homogentisic Acid 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Haust MD: Atherosclerosis in childhood. In Rosenberg HS, Bolande RP (eds): Perspectives in Pediatric Pathology. Chicago: Year Book, 1978, Vol 4, pp 155–216.Google Scholar
  2. 2.
    Char F: Tables of heritable cardiovascular conditions and associated syndromes. BDOAS 8:313–322, 1972.Google Scholar
  3. 3.
    Taylor WJ: Genetics and the cardiovascular system. In Hurst JW (ed): The Heart, Arteries and Veins, 4th Ed. New York: McGraw-Hill, 1978, p 753.Google Scholar
  4. 4.
    Rowe RD, Uchida IA, Char F: Heart disease associated with chromosomal abnormalities. In Keith JD, Rowe RD, Vlad P (eds): Heart Disease in Infancy and Child-hood, 3d Ed. New York: Macmillan, 1978, pp 897–925.Google Scholar
  5. 5.
    Noonan JA: Association of congenital heart disease with syndromes or other defects. Pediatr Clin North Am 25:797–816, 1978.PubMedGoogle Scholar
  6. 6.
    Perloff JK: The Clinical Recognition of Congenital Heart Disease, 2d Ed. Philadelphia: Saunders, 1978.Google Scholar
  7. 7.
    Wald EB (Ed): Heart Disease: A Textbook of Cardiovascular Medicine. Philadelphia: Saunders, 1978.Google Scholar
  8. 8.
    Roberts WC (Ed): Congenital Heart Disease in Adults. Philadelphia: FA Davis, 1979.Google Scholar
  9. 9.
    Shows TB, McAlphine PJ: The 1979 catalog of human genes and chromosome assignments. Cytogenet Cell Genet 25:117–127, 1979.PubMedCrossRefGoogle Scholar
  10. Ferrans VJ, Boyce SW: Metabolic and familial diseases. In Silver MD (ed): Cardiovascular Pathology. New York: Churchill Livingstone, 1983, Vol 2, pp 945–1004.Google Scholar
  11. 11.
    Gerald PS: Sex chromosome disorders. N Engl J Med 294:706–708, 1976.PubMedCrossRefGoogle Scholar
  12. 12.
    De Grouchy J, Turkleau C: Clinical Atlas of Human Chromosomes. New York: John Wiley, 1977.Google Scholar
  13. 13.
    Carr DH, Gideon M: Population cytogenetics of human abortuses. In Hook EB, Porter IH (eds): Population Cytogenetics. Studies in Humans. New York: Academic Press, 1977.Google Scholar
  14. 14.
    An international system for human cytogenetic nomenclature (1978). BDOAS XIV(8), 1978.Google Scholar
  15. 15.
    Grumbach MM, Conte FA: Disorders of sexual differentiation. In Wilson ID, Foster DW (eds): Williams Textbook of Endocrinology, 7th Ed. Philadelphia: Saunders, 1985, pp 312–401.Google Scholar
  16. 16.
    Breg WR: Down syndrome. A review of recent progress in research. Pathobiol Annu 7:257–303, 1977.PubMedGoogle Scholar
  17. 17.
    Fleisher GR, Buck BE, Cornfeld D: Primary intimal fibroplasia in a child with Down’s syndrome. Am J Dis Child 132:700–703, 1978.PubMedGoogle Scholar
  18. 18.
    Martin GM, Hoehn H: Genetics and human disease. Hum Pathol 5:387–405, 1974.PubMedCrossRefGoogle Scholar
  19. 19.
    Thompson JS, Thompson MW: Genetics in Medicine. Philadelphia: Saunders, 1980.Google Scholar
  20. 20.
    McKusick VA: The anatomy of the human genome. Am J Med 69:267–276, 1980.PubMedCrossRefGoogle Scholar
  21. 21.
    Kronenberg HM: Looking at genes. N Engl J Med 307:50–52, 1982.PubMedCrossRefGoogle Scholar
  22. 22.
    Storstein O, Rokseth R, Sörland S: Congenital heart disease in a clinical material. An analysis of 1,000 consecutive cases. Acta Med Scand 176:195–200, 1964.PubMedCrossRefGoogle Scholar
  23. 23.
    Higgins ITT: The epidemiology of congenital heart disease. J Chron Dis 18:699–721, 1965.PubMedCrossRefGoogle Scholar
  24. 24.
    Nora JJ, Nora AH: The evolution of specific genetic and environmental counselling in congenital heart diseases. Circulation 57:205–213, 1978.PubMedGoogle Scholar
  25. 25.
    Friedman WF: Congenital heart disease in infancy and childhood. In Braunwald E (ed): Heart Disease. A Textbook of Cardiovascular Medicine. Philadelphia: Saunders, 1980, pp 967–1056.Google Scholar
  26. 26.
    Elliott LP, Newfeld HN, Anderson RC, Adams P, Edwards JE: Complete transposition of the great vessels. I. An anatomic study of sixty cases. Circulation 27:1105–1117, 1963.Google Scholar
  27. 27.
    Lev M, Alcalde VM, Baffes TG: Pathologic anatomy of complete transposition of the arterial trunks. Pediatrics 28:293–306, 1961.PubMedGoogle Scholar
  28. 28.
    Archer HE, Dormer AE, Scowen EF, Watts RWE: Primary hyperoxaluria. Lancet 273:320–322, 1957.PubMedCrossRefGoogle Scholar
  29. 29.
    Stauffer M: Oxalosis. Report of a case, with a review of the literature and discussion of the pathogenesis. N Engl J Med 263:386–390, 1960.PubMedCrossRefGoogle Scholar
  30. 30.
    Chisholm GD, Heard BE: Oxalosis. Br J Surg 50:78–92, 1962.PubMedCrossRefGoogle Scholar
  31. 31.
    Hockaday TDR, Clayton JE, Frederick EW, Smith LH Jr: Primary hyperoxaluria. Medicine 43:315–345, 1964.PubMedGoogle Scholar
  32. 32.
    Blackburn WE, McRoberts JW, Bhathena D, Vazquez M, Luke RG: Severe vascular complications in oxalosis after bilateral nephrectomy. Ann Intern Med 82:44–46, 1975.PubMedGoogle Scholar
  33. 33.
    Williams HE, Smith LH Jr: Primary hyperoxaluria. In Stanbury JB, Wyngaarden JB, Fredrickson DS, Goldstein JL, Brown MS (eds): The Metabolic Basis of Inherited Disease, 5th Ed. New York: McGraw-Hill, 1983, pp 204–228.Google Scholar
  34. 34.
    Chaplin AJ: Histopathological occurrence and characterisation of calcium oxalate: A review. J Clin Pathol 30:800–811, 1977.PubMedCrossRefGoogle Scholar
  35. 35.
    Beil E, Seibel K, Riecker G: Herzerkrankung bei primärer Oxalose. Klin Wochenschr 47:513–518, 1969.PubMedCrossRefGoogle Scholar
  36. 36.
    Coltart DJ, Hudson REB: Primary oxalosis of the heart: A cause of heart block. Br Heart J 33:315–319, 1971.PubMedCrossRefGoogle Scholar
  37. 37.
    Fayemi AO, Ali M, Braun EV: Oxalosis in hemodialysis patients. A pathologic study of 80 cases. Arch Pathol Lab Med 103:58–62, 1979.PubMedGoogle Scholar
  38. 38.
    Tonkin AM, Mond HG, Mathew TH, Solman JG: Primary oxalosis with myocardial involvement and heart block. Med J Aust 1:873–874, 1976.PubMedGoogle Scholar
  39. 39.
    West RR, Salyer WR, Hutchins GM: Adult-onset primary oxalosis with complete heart block. Johns Hopkins Med J Aust 133:195–200, 1973.Google Scholar
  40. 40.
    Milch RA: Studies of alcaptonuria: Inheritance of 47 cases in eight highly interrelated Dominican kindreds. Am J Hum Genet 12:76–85, 1960.PubMedGoogle Scholar
  41. 41.
    Reginato A, Riera M, Martinez V, Ruiz F: Alkaptonuria, ochronotic arthropathy and aortic stenosis. Rev Med Chile 100:529–533, 1972.PubMedGoogle Scholar
  42. 42.
    Srsen S, Cisarik F, Pasztor L, Harmecko L: Alkaptonuria in the Trencin district of Czechoslovakia. Am J Med Genet 2:159–166, 1978.PubMedCrossRefGoogle Scholar
  43. 43.
    Moran TJ, Yunis EJ: Studies on ochronosis. 2. Effects of injection of homogentisic acid and ochronotic pigment in experimental animals. Am J Pathol 40:359–369, 1962.PubMedGoogle Scholar
  44. 44.
    Cooper JA, Moran TJ: Studies on ochronosis. I. Report of case with death from ochronotic nephrosis. Arch Pathol 64:46–53, 1957.Google Scholar
  45. 45.
    Beddard AP: Ochronosis associated with carboluria. Q J Med 3:329–336, 1910.Google Scholar
  46. 46.
    O’Brien WM, LaDu BN, Bunim JJ: Biochemical, pathologic and clinical aspects of alcaptonuria, ochronosis and ochronotic arthropathy: Review of world literature (1584–1962). Am J Med 34:813–838, 1963.CrossRefGoogle Scholar
  47. 47.
    Bondurant RE, Henry JB: Pathogenesis of ochronosis in experimental alkaptonuria of the white rat. Lab Invest 14:62–69, 1965.PubMedGoogle Scholar
  48. 48.
    Attwood HD, Clifton S, Mitchell RE: A histological, histochemical and ultrastructural study of dermal ochronosis. Pathology 3:115–121, 1971.PubMedCrossRefGoogle Scholar
  49. 49.
    Galdston M, Steele JM, Dobriner K: Alcaptonuria and ochronosis. With a report of three patients and metabolic studies in two. Am J Med 13:432–452, 1952.PubMedCrossRefGoogle Scholar
  50. 50.
    Levine HD, Parisi AF, Holdsworth DE, Cohn LH: Aortic valve replacement for ochronosis of the aortic valve. Chest 74:466–467, 1978.PubMedCrossRefGoogle Scholar
  51. 51.
    Lichtenstein L, Kaplan L: Hereditary ochronosis. Pathologic changes observed in two necropsied cases. Am J Pathol 30:99–125, 1954.PubMedGoogle Scholar
  52. 52.
    Buja LM, Khoi NB, Roberts WC: Clinically significant cardiac amyloidosis. Clinicopathologic findings in 15 patients. Am J Cardiol 26:394–405, 1970.PubMedCrossRefGoogle Scholar
  53. 53.
    Mahloudji M, Teasdall RD, Adamkiewicz JJ, Hartmann WH, Lambird PA, McKusick VA: The genetic amyloidoses. With particular reference to hereditary neuropathic amyloidosis, type II (Indiana or Rukavina type). Medicine 48:1–37, 1969.PubMedCrossRefGoogle Scholar
  54. 54.
    Hovig T, Gjone E: Familial lecithin: Cholesterol acyltransferase deficiency. Scand J Clin Lab Invest 33(Suppl 134–139): 135–146, 1974.Google Scholar
  55. 55.
    Haust MD: Arterial involvement in genetic diseases. Am J Cardiovasc Pathol 1:231–285, 1987.PubMedGoogle Scholar
  56. 56.
    Beighton P: The Ehlers-Danlos Syndrome. London: William Heinemann, 1970.Google Scholar
  57. 57.
    Hunter GC, Malone JM, Moore WS, Misiorowski RL, Chvapil M: Vascular manifestations in patients with Ehlers-Danlos syndrome. Arch Surg 117:495–498, 1982.PubMedGoogle Scholar
  58. 58.
    Goodman RM, Smith EW, Paton D, et al: Pseudoxanthoma elasticum: A clinical and histopathological study. Medicine 42:297–334, 1963.PubMedCrossRefGoogle Scholar
  59. 59.
    Swanton RH, Brooksby IAB, Davies MJ, Coltart DJ, Jenkins BS, Webb-Peploe MM: Systolic and diastolic ventricular function in cardiac amyloidosis. Studies in six cases diagnosed with endomyocardial biopsy. Am J Cardiol 39:658–664, 1977.PubMedCrossRefGoogle Scholar
  60. 60.
    Factor SM, Biempica L, Goldfischer S: Coronary intimal sclerosis in Morquio’s syndrome. Virchows Arch [Pathol Anat] 379:1–10, 1978.CrossRefGoogle Scholar
  61. 61.
    Schenk EA, Haggerty J: Morquio’s disease. A radiologic and morphologic study. Pediatrics 34:839–850, 1964.PubMedGoogle Scholar
  62. 62.
    James TN, Fisch C: Observations on the cardiovascular involvement in Friedreich’s ataxia. Am Heart J 66:164–175, 1963.PubMedCrossRefGoogle Scholar
  63. 63.
    James TN: Observations on the cardiovascular involvement, including the cardiac conduction system, in progressive muscular dystrophy. Am Heart J 63:48–56, 1962.PubMedCrossRefGoogle Scholar
  64. 64.
    Perloff JK, DeLeon AC Jr, O’Doherty D: The cardiomyopathy of progressive muscular dystrophy. Circulation 33:625–648, 1966.PubMedGoogle Scholar
  65. 65.
    Danks DM, Campbell PE, Stevens BJ, Mayne V, Cartwright E: Menkes’s kinky hair syndrome. An inherited defect in copper absorption with widespread effects. Pediatrics 50:188–201, 1972.PubMedGoogle Scholar
  66. 66.
    Martin JJ, Flament-Durnad J, Farriaux JP, Buyssens N, Ketelbant-Balasse P, Jansen C: Menkes kinky-hair disease. A report on its pathology. Acta Neuropathol (Berl) 42:25–32, 1978.CrossRefGoogle Scholar
  67. 67.
    Oakes BW, Banks DM, Campbell PE: Human copper deficiency: Ultrastructural studies of the aorta and skin in a child with Menkes’ syndrome. Exp Mol Pathol 25:82–98, 1976.PubMedCrossRefGoogle Scholar
  68. 68.
    Wheeler EM, Roberts PF: Menkes’s steely hair syndrome. Arch Dis Child 51:269–274, 1976.PubMedCrossRefGoogle Scholar
  69. 69.
    Desnick RJ, Sweeley CC: Fabry’s disease: α-Galactosidase A deficiency. In Stanbury JB, Wyngaarden JB, Fredrickson DS, Goldstein JL, Brown MS (eds): The Metabolic Basis of Inherited Disease, 5th Ed. New York: McGraw-Hill, 1983, pp 906–944.Google Scholar
  70. 70.
    Parkinson JE, Sunshine A: Angiokeratoma corporis diffusum universale (Fabry) presenting as suspected myocardial infarction and pulmonary infarcts. Am J Med 31:951–958, 1961.PubMedCrossRefGoogle Scholar
  71. 71.
    Becker AE, Schoorl R, Balk AG, Van der Heide RM: Cardiac manifestations of Fabry’s disease. Report of a case with mitral insufficiency and electrocardiographic evidence of myocardial infarction. Am J Cardiol 36:829–835, 1975.PubMedCrossRefGoogle Scholar
  72. 72.
    Desnick RJ, Blieden LC, Sharp HL, Hofschire PJ, Moller JH: Cardiac valvular anomalies in Fabry disease. Clinical, morphologic, and biochemical studies. Circulation 54:818–825, 1976.PubMedGoogle Scholar
  73. 73.
    Duncan C, McLeod GM: Angiokeratoma corporis diffusum universale (Fabry’s disease): A case with gross myocardial involvement. Aust Ann Med 19:58–61, 1970.PubMedGoogle Scholar
  74. 74.
    Nikkilä EA: Familial lipoprotein lipase deficiency and related disorders of chylomicron metabolism. In Stanbury JB, Wyngaarden JB, Fredrickson DS, Goldstein JL, Brown MS (eds): The Metabolic Basis of Inherited Diseases, 5th Ed. New York: McGraw-Hill, 1983, pp 622–642.Google Scholar
  75. 75.
    Brown MS, Goldstein JL, Fredrickson DS: Familial type 3 hyperlipoproteinemia (dysbetalipoproteinemia). In Stanbury JB, Wyngaarden JB, Fredrickson DS, Goldstein JL, Brown MS (eds): The Metabolic Basis of Inherited Diseases, 5th Ed. New York: McGraw-Hill, 1983, pp 655–671.Google Scholar
  76. 76.
    Goldstein JL, Kita T, Brown MS: Defective lipoprotein receptors and atherosclerosis. Lessons from an animal counterpart of familial hypercholesterolemia. N Engl J Med 309:288–296, 1983.PubMedCrossRefGoogle Scholar
  77. 77.
    Goldstein JL, Brown MS: Familial hypercholesterolemia. In Stanbury JB, Wyngaarden JB, Fredrickson DS, Goldstein JL, Brown MS (eds): The Metabolic Basis of Inherited Diseases, 5th Ed. New York: McGraw-Hill, 1983, pp 672–712.Google Scholar
  78. 78.
    Lippel K, Tyroler H, Eder H, Gotto A Jr, Vahouny G: Relationship of hypertriglyceridemia to atherosclerosis. Arteriosclerosis 1:406–417, 1981.PubMedCrossRefGoogle Scholar
  79. 79.
    Grundy SM: Pathogenesis of hypertriglyceridemia in man. In Carlson LA, Olsson AG (eds): Treatment of Hyperlipoproteinemia. New York: Raven Press, 1984, pp 21–34.Google Scholar
  80. 80.
    Schaefer EJ, Levy RI: Pathogenesis and management of lipoprotein disorders. N Engl J Med 312:1300–1310, 1985.PubMedCrossRefGoogle Scholar
  81. 81.
    Goldstein JL, Brown MS: Familial hypercholesterolemia: pathogenesis of a receptor disease. Johns Hopkins Med J 143:8–16, 1978.PubMedGoogle Scholar
  82. 82.
    Morganroth J, Levy RI, Fredrickson DS: The biochemical, clinical and genetic features of type III hyperlipoproteinemia. Ann Intern Med 82:158–174, 1975.PubMedGoogle Scholar
  83. 83.
    Roberts WC, Levy RI, Fredrickson DS: Hyperlipoproteinemia. A review of the five types with first report of necropsy findings in type 3. Arch Pathol Lab Med 90:45–56, 1970.Google Scholar
  84. 84.
    Haust MD, Gilbert EF, Levy J, Hahn MF: Hypoplastic aorta-a failure of remodelling. Pediatr Pathol 6:101–108, 1986.Google Scholar
  85. 85.
    Haust MD: Genetic diseases and atherosclerotic lesions. In Crepaldi G, Gotto AM, Manzato E, Baggio G (eds): Atherosclerosis VIII. Amsterdam : Excerpta Medica, International Congress Series 817, 1989, pp 3–10.Google Scholar
  86. 86.
    Gomez MR: Tuberous Sclerosis. New York: Raven Press, 1979.Google Scholar
  87. Comings DE: Review of Gomez’s “Tuberous Sclerosis.” Am J Hum Genet 32:285–286, 1980.Google Scholar
  88. 88.
    Wilson J, Carter C: Genetics of tuberose sclerosis. (Letter.) Lancet 1:340, 1978.PubMedCrossRefGoogle Scholar
  89. 89.
    Sybert VP, Hall JG: Inheritance of tuberous sclerosis. (Letter.) Lancet 1:783, 1979.PubMedCrossRefGoogle Scholar
  90. 90.
    Bender BL, Yunis EJ: The pathology of tuberous sclerosis. Pathol Annu 1:339–382, 1982.Google Scholar
  91. 91.
    Anderson DE, Tannen RL: Tuberous sclerosis and chronic renal failure. Potential confusion with polycystic kidney disease. Am J Med 47:163–168, 1969.PubMedCrossRefGoogle Scholar
  92. 92.
    McWilliam RC, Stephenson JBP: Depigmented hair: The earliest sign of tuberous sclerosis. Arch Dis Child 53:961–963, 1978.PubMedCrossRefGoogle Scholar
  93. 93.
    Freycon F, Mollard PC, Hermier M, et al: Anevrysme de l’aorte abdominale au cours d’une sclerose tubereuse de Bourneville. Pediatrie 26:421–427, 1971.PubMedGoogle Scholar
  94. 94.
    Larbre F, Loire R, Guibaud P, Lauras B, Weill B: Observation clinique et anatomique d’un anevrysme de l’aorte au cours d’une sclerose tubereuse de Bourneville. Arch Fr Pediatr 28:975–984, 1971.PubMedGoogle Scholar
  95. 95.
    Dutton RV, Singleton EB: Tuberous sclerosis: A case report with aortic aneurysm and unusual rib changes. Pediatr Radiol 3:184–186, 1975.PubMedCrossRefGoogle Scholar
  96. 96.
    Hagood CO, Garvin DD, Lachina FM, Polsky WS, Ball TP, Bobroff LM: Abdominal aortic aneurysm and renal hamartoma in an infant with tuberous sclerosis. Surgery 79:713–715, 1976.PubMedGoogle Scholar
  97. 97.
    Imaizumi M, Nukada T, Yoneda S, Takano T, Hasegawa K, Abe H: Tuberous sclerosis with moyamoya disease: Case report. Med J Osaka Univ, 28:345–353, 1978.PubMedGoogle Scholar
  98. Hurst JW (ed): The Heart, Arteries and Veins, 4th Ed. New York: McGraw-Hill, 1978.Google Scholar
  99. 99.
    Schwartz PL, Beards JA, Maris PJG: Tuberous sclerosis associated with a retinal angioma. Am J Opthalmol 90:485–488, 1980.Google Scholar
  100. 100.
    Rolfes DB, Towbin R, Bove KE: Vascular dysplasia in a child with tuberous sclerosis. Pediatr Pathol 3:359–373, 1985.PubMedCrossRefGoogle Scholar
  101. 101.
    Stanley JC, Gewertz BL, Bove EL, Sottiurai V, Fry WJ: Arterial fibrodysplasia: Histopathologic character and current etiologic concepts. Arch Surg 110:561–565, 1975.PubMedGoogle Scholar
  102. 102.
    Sottiurai VS, Fry WJ, Stanley J: Ultrastructure of medial smooth muscle and myofibroblasts in human arterial dysplasia. Arch Surg 113:1280–1288, 1978.PubMedGoogle Scholar
  103. 103.
    O’Brien JS: The gangliosidoses. In: Stanbury JB, Wyngaarden JB, Fredrickson DS, Goldstein JL, Brown MS (eds): The Metabolic Basis of Inherited Disease, 5th Ed. New York: McGraw-Hill, 1983, pp 945–969.Google Scholar
  104. 104.
    Landing BH, Silverman FN, Craig JM, Jacoby MD, Lahey ME, Chadwick DL: Familial neurovisceral lipidosis. Am J Dis Child 108:503–522, 1964.PubMedGoogle Scholar
  105. 105.
    Suzuki K, Suzuki K, Chen GC: Morphological, histochemical and biochemical studies on a case of systemic late infantile lipidosis (generalized gangliosidosis). J Neuropathol Exp Neurol 27:15–38, 1968.PubMedCrossRefGoogle Scholar
  106. 106.
    Yamano T, Shimada M, Okada S, et al: Ultrastructural study on nervous system of fetus with GM1-gangliosidosis type I. Acta Neuropathol (Berl) 61:15–20, 1983.CrossRefGoogle Scholar
  107. 107.
    Abu-Dalu KI, Tamary H, Livni N, Rivkind AI, Yatziv S: GM1 gangliosidosis presenting as neonatal ascites. J Pediatr 100:940–943, 1982.PubMedCrossRefGoogle Scholar
  108. 108.
    Benson PF, Babarik A, Brown SP, Mann TP: GM1-generalized gangliosidosis variant with cardiomegaly. Postgrad Med J 52:159–165, 1976.PubMedCrossRefGoogle Scholar
  109. 109.
    Kohlschütter A, Sieg K, Schulte FJ, Hayek HW, Goebel HH: Infantile cardiomyopathy and neuromyopathy with β-galactosidase deficiency. Eur J Pediatr 139:75–81, 1982.PubMedCrossRefGoogle Scholar
  110. 110.
    Nakano T, Ikeda S, Kondo K, Yanagisawa N, Tsuji S: Adult GM1-gangliosidosis: Clinical patterns and rectal biopsy. Neurology 35:875–880, 1985.PubMedGoogle Scholar
  111. 111.
    Yamano T, Shimada M, Okada S, Yutaka T, Kato T, Yabuuchi H: Ultrastructural study of biopsy specimens of rectal mucosa. Its use in neuronal storage diseases. Arch Pathol Lab Med 106:673–677, 1982.PubMedGoogle Scholar
  112. 112.
    Takahashi K, Naito M: Lipid storage disease. II. Ultrastructural pathology of lipid storage cells in sphingolipidoses. Acta Pathol Jpn 35:385–408, 1985.PubMedGoogle Scholar
  113. 113.
    Spycher MA: Electron microscopy: A method for the diagnosis of inherited metabolic storage diseases. Electron microscopy in diagnosis. Pathol Res Pract 167:118–135, 1980.PubMedGoogle Scholar
  114. 114.
    Elleder M: Ito cells in lysosomal storage disorders. An ultrastructural study. Virch Arch [Cell Pathol] 46:13–19, 1984.CrossRefGoogle Scholar
  115. 115.
    Haust MD: The genetic mucopolysaccharidoses (GMS). Int Rev Exp Pathol 12:251–314, 1973.PubMedGoogle Scholar
  116. 116.
    McKusick VA, Neufeld EF: The mucopolysaccharide storage diseases. In Stanbury JB, Wyngaarden JB, Fredrickson DS, Goldstein JL, Brown MS (eds): The Metabolic Basis of Inherited Diseases, 5th Ed. New York: McGraw-Hill, 1983, pp 751–777.Google Scholar
  117. 117.
    Orizaga M, Haust MD, Bryans AM, Frank H: Electron microscopic study of liver in Hurler’s syndrome. Fed Proc 22:484, 1963.Google Scholar
  118. 118.
    Haust MD, Orizaga M, Bryans AM, Frank HF: The fine structure of liver in children with Hurler’s syndrome. Exp Mol Pathol 10:141–161, 1969.PubMedCrossRefGoogle Scholar
  119. 119.
    McKusick VA: Mendelian Inheritance in Man. Catalog of Autosomal Dominant, Autosomal Recessive, and X-Linked Phenotypes, 6th Ed. Baltimore: Johns Hopkins University Press, 1983, pp 151–153, 316–317, 695–697, 958, 1004, 1009.Google Scholar
  120. 120.
    Cupo LN, Pyeritz RE, Olson JL, McPhee SJ, Hutchins GM, McKusick VA: Ehlers-Danlos syndrome with abnormal collagen fibrils, sinus of Valsalva aneurysms, myocardial infarction, panacinar emphysema and cerebral heterotopias. Am J Med 71:1051–1058, 1981.PubMedCrossRefGoogle Scholar
  121. 121.
    Sulh HMB, Steinmann B, Rao VH, Dudin G, Zeid JA, Slim M, DerKaloustian VM: Ehlers-Danlos syndrome type IV D: An autosomal recessive disorder. Clin Genet 25:278–287, 1984.PubMedCrossRefGoogle Scholar
  122. 122.
    Arneson MA, Hammerschmidt DE, Furcht LT, King RA: A new form of Ehlers-Danlos syndrome: Fibronectin corrects defective platelet function. JAMA 244:144–147, 1980.PubMedCrossRefGoogle Scholar
  123. 123.
    Hollister DW: Heritable disorders of connective tissue: Ehlers-Danlos syndrome. Pediatr Clin North Am 25:575–591, 1978.PubMedGoogle Scholar
  124. 124.
    Prockop DJ, Kivirikko KI: Heritable diseases of collagen. N Engl J Med 311:376–386, 1984.PubMedCrossRefGoogle Scholar
  125. 125.
    Hollister DW, Byers PH, Holbrook KA: Genetic disorders of collagen metabolism. Adv Hum Genet 12:1–87, 1982.PubMedGoogle Scholar
  126. 126.
    Minor RR: Collagen metabolism. Am J Pathol 98:225–280, 1980.PubMedGoogle Scholar
  127. 127.
    Pyeritz RE, Stolle CA, Parfrey NA, Myers JC: Ehlers-Danlos syndrome IV due to a novel defect in type III procollagen. Am J Med Genet 19:607–622, 1984.PubMedCrossRefGoogle Scholar
  128. Stolle CA, Pyeritz RE, Myers JC, Prockop DJ: Synthesis of an altered type III procollagen in a patient with type IV Ehlers-Danlos syndrome. J Biol Chem 260:1937–1944, 1985.PubMedGoogle Scholar
  129. 129.
    Pope FM, Nicholls AC, Jones PM, Wells RS, Lawrence D: EDS IV (acrogeria): New autosomal dominant and recessive types. J R Soc Med 73:180–186, 1980.PubMedGoogle Scholar
  130. 130.
    Beighton P: Lethal complications of Ehlers-Danlos syndrome. Br Med J 3:656–659, 1968.PubMedCrossRefGoogle Scholar
  131. 131.
    Schoolman A, Kepes JJ, : Bilateral spontaneous carotid-cavernous fistulae in Ehlers-Danlos syndrome. Case report. J Neurosurg 26:82–86, 1967.PubMedCrossRefGoogle Scholar
  132. 132.
    Umlas J: Spontaneous rupture of the subclavian artery in the Ehlers-Danlos syndrome. Hum Pathol 3:121–126, 1972.PubMedCrossRefGoogle Scholar
  133. 133.
    Barabas AP: Vascular complications in the Ehlers-Danlos syndromes. With special reference to the “arterial type” or Sack’s syndrome. J Cardiovasc Surg (Torino) 13:160–167, 1972.Google Scholar
  134. 134.
    Dalton ML, Bricker DL, Nannini L: Spontaneous rupture of the subclavian artery and innominate vein. Arch Surg 109:552–554, 1974.PubMedGoogle Scholar
  135. 135.
    Krane SM, Trelstad RL: Case records of the Massachusetts General Hospital, case 3–1979. N Engl J Med 300:129–135, 1979.CrossRefGoogle Scholar
  136. 136.
    Rudd NL, Nimrod C, Holbrook KA, Byers PH: Pregnancy complications in type IV Ehlers-Danlos syndrome. Lancet 1:50–53, 1983.PubMedCrossRefGoogle Scholar
  137. 137.
    Sheiner NM, Miller N, Lachance C: Arterial complications of Ehlers-Danlos syndrome. J Cardiovasc Surg 26:291–296, 1985.Google Scholar
  138. 138.
    Imahori S, Bannerman RM, Graf CJ, Brennan JC: Ehlers-Danlos syndrome with multiple arterial lesions. Am J Med 47:967–977, 1969.PubMedCrossRefGoogle Scholar
  139. 139.
    Burnett HF, Bledsoe JH, Char F, Williams GD: Abdominal aortic aneurysmectomy in a 17-year-old patient with Ehlers-Danlos syndrome: Case report and review of the literature. Surgery 74:617–620, 1973.PubMedGoogle Scholar
  140. 140.
    Williams JL: Multiple aneurysms in a child. Proc R Soc Med 68:523–525, 1975.PubMedGoogle Scholar
  141. 141.
    Short DW: Multiple congenital aneurysms in childhood: Report of a case. Br J Surg 65:509–512, 1978.PubMedCrossRefGoogle Scholar
  142. 142.
    Byers PH, Holbrook KA, McGillivray B, MacLeod PM, Lowry RB: Clinical and ultrastructural heterogeneity of type IV Ehlers-Danlos syndrome. Hum Genet 47:141–150, 1979.PubMedCrossRefGoogle Scholar
  143. 143.
    Pope FM, Martin GR, Lichtenstein JR, et al: Patients with Ehlers-Danlos syndrome type IV lack type III collagen. Proc Natl Acad Sci USA 72:1314–1316, 1975.PubMedCrossRefGoogle Scholar
  144. 144.
    Byers PH, Barsh GS, Holbrook KA: Molecular mechanisms of connective tissue abnormalities in the Ehlers-Danlos syndrome. Coll Relat Res 1:475–489, 1981.PubMedGoogle Scholar
  145. 145.
    Clark JG, Kuhn C III, Uitto J: Lung collagen in type IV Ehlers-Danlos syndrome: Ultrastructural and biochemical studies. Am Rev Respir Dis 122:971–978, 1980.PubMedGoogle Scholar
  146. 146.
    Byers PH, Holbrook KA, Barsh GS, Smith LT, Bornstein P: Altered secretion of type III procollagen in a form of type IV Ehlers-Danlos syndrome. Biochemical studies in cultured fibroblasts. Lab Invest 44:336–341, 1981.PubMedGoogle Scholar
  147. 147.
    Huang W, Haust MD: Proteoglycans in human atherosclerotic lesions—a pilot quantitative study by ruthenium red. Histopathology 8:835–845, 1984.PubMedCrossRefGoogle Scholar
  148. 148.
    Grieco AJ: Homocystinuria: Pathogenetic mechanisms. Am J Med Sci 273:120–132, 1997.CrossRefGoogle Scholar
  149. 149.
    Carson NAJ, Dent CE, Field CMB, Gaull GE: Homocystinuria. Clinical and pathological review of ten cases. J Pediatr 66:565–583, 1965.PubMedCrossRefGoogle Scholar
  150. 150.
    Gibson JB, Carson NAJ, Neill DW: Pathological findings in homocystinuria. J Clin Pathol 17:427–437, 1964.PubMedCrossRefGoogle Scholar
  151. 151.
    Lindsay J Jr, Meshel JC, Patterson RH: The cardiovascular manifestations of sickle cell disease. Arch Intern Med 133:643–651, 1974.PubMedCrossRefGoogle Scholar
  152. 152.
    Rubier S, Fleischer RA: Sickle cell states and cardiomyopathy. Sudden death due to pulmonary thrombosis and infarction. Am J Cardiol 19:867–873, 1967.CrossRefGoogle Scholar
  153. 153.
    Atkins L: Progeria. Report of a case with postmortem findings. N Engl J Med 250:1065–1069, 1954.PubMedCrossRefGoogle Scholar
  154. 154.
    Gabr M, Hashem N, Hashem M, Fahmi A, Safouh M: Progeria, a pathologic study. J Pediatr 57:70–77, 1960.PubMedCrossRefGoogle Scholar
  155. 155.
    Makous N, Friedman S, Yakovac W, Maris EP: Cardiovascular manifestations in progeria. Report of clinical and pathologic findings in a patient with severe arteriosclerotic heart disease and aortic stenosis. Am Heart J 64:334–346, 1962.PubMedCrossRefGoogle Scholar
  156. 156.
    Reichel W, Garcia-Bunuel R: Pathologic findings in progeria: Myocardial fibrosis and lipofuscin pigment. Am J Clin Pathol 53:243–253, 1970.PubMedGoogle Scholar
  157. 157.
    Perkins DG, Haust MD: Ultrastructure of myocardium in the Hurler Syndrome: Possible relation to cardiac function. Virchows Arch A 394:195–205, 1982.Google Scholar
  158. 158.
    Blank E, Linder D: I-cell disease (mucolipidosis II): A lysosomopathy. Pediatrics 54:797–805, 1974.PubMedGoogle Scholar
  159. 159.
    Glaser JH, McAlister WH, Sly WS: Genetic heterogeneity in multiple lysosomal hydrolase deficiency. J Pediatr 85:192–198, 1974.PubMedCrossRefGoogle Scholar
  160. 160.
    Nagashima K, Sakakibara K, Endo H, Konishi Y, Nakamura N, Suzuki Y, Abe T: I-cell disease (mucolipidosis II). Pathological and biochemical studies of an autopsy case. Acta Pathol Jpn 27:251–264, 1977.PubMedGoogle Scholar
  161. 161.
    Wood DH: Cerebrovascular complications of sickle cell anemia. Stroke 9:73–75, 1978.PubMedCrossRefGoogle Scholar
  162. 162.
    Botreau-Rousell P, Drobinski G, Lévy R, Vachon JM, Nivet M, Grosgogeat Y: Infarctus du myocarde et drépanocytose hétérozygote. A propos de 2 cas. Arch Mal Coeur 70:141–147, 1977.Google Scholar
  163. 163.
    Fleischer RA, Rubier S: Primary cardiomyopathy in nonanemic patients. Association with sickle cell trait. Am J Cardiol 22:532–537, 1968.PubMedCrossRefGoogle Scholar
  164. 164.
    Walkley SU, Wurzelmann S, Purpura DP: Ultrastructure of neurites and meganeurites of cortical pyramidal neurons in feline gangliosidosis as revealed by the combined Golgi-EM technique. Brain Res 211:393–398, 1981.PubMedCrossRefGoogle Scholar
  165. 165.
    Rodrigues M, O’Brien JS, Garrett RS, Powell HC: Canine GM1 gangliosidosis. An ultrastructural and biochemical study. J Neuropathol Exp Neurol 41:618–629, 1982.CrossRefGoogle Scholar
  166. 166.
    Shull RM, Helman RG, Spellacy E, Constantopoulos G, Munger RJ, Neufeld EF: Morphologic and biochemical studies of canine mucopolysaccharidosis I. Am J Pathol 114:487–495, 1984.PubMedGoogle Scholar
  167. 167.
    Damle SP, Minor RR, Gregory JD: Proteoglycans in dog skin in a genetic dominant trait that shows defects in collagen fibrillogenesis. In Davidson EA, Williams JC, Di Ferrante NM (eds): Glycoconjugates. Proceedings of the VHIth International Symposium. New York: Praeger, 1985, Vol 1, p 301.Google Scholar

Copyright information

© Springer-Verlag New York Inc. 1990

Authors and Affiliations

  • M. Daria Haust
    • 1
  1. 1.Department of Pathology, Pediatrics, and Obstetrics and GynecologyUniversity of Western Ontario and the Children’s Psychiatric Research InstituteOntarioCanada

Personalised recommendations